Pivotal bioVenture Partners Investment Advisor LLC
13 holdingsFiling period: 2026-06-30Current AUM: $257.2Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PCVX | Vaxcyte Inc | 1.43M | $82.9M | $88.4M | 34.38% | +53.0K | 2026-06-30 |
| 2 | ARQT | Arcutis Biotherapeutics Inc | 1.27M | $33.2M | $40.6M | 15.78% | -90,609 | 2026-06-30 |
| 3 | TRVI | Trevi Therapeutics Inc | 1.74M | $32.5M | $23.6M | 9.19% | +188.9K | 2026-06-30 |
| 4 | AVLN | Avalyn Pharmaceuticals Inc | 966.8K | $31.8M | $24.8M | 9.63% | -- | 2026-06-30 |
| 5 | EVMN | Evommune Inc | 1.93M | $25.6M | $13.0M | 5.04% | -- | 2026-06-30 |
| 6 | MPLT | Maplight Therapeutics Inc | 611.4K | $21.9M | $4.6M | 1.80% | -1 | 2026-06-30 |
| 7 | — | Oculis Holding AG | 1.51M | $20.9M | $20.9M | 8.12% | -174,033 | 2026-06-30 |
| 8 | BIOA | Bioage Labs Inc | 653.4K | $16.0M | $3.8M | 1.49% | -- | 2026-06-30 |
| 9 | IMNM | Immunome Inc | 732.5K | $15.5M | $13.3M | 5.19% | -- | 2026-06-30 |
| 10 | ZBIO | Zenas Biopharma Inc | 490.8K | $12.5M | $13.9M | 5.42% | -101,225 | 2026-06-30 |
| 11 | AVTX | Avalo Therapeutics Inc | 434.0K | $8.0M | $3.1M | 1.21% | +138.1K | 2026-06-30 |
| 12 | RLYB | Rallybio Corp | 300.6K | $4.8M | $4.7M | 1.82% | -- | 2026-06-30 |
| 13 | RXRX | Recursion Pharmaceuticals in | 595.5K | $2.2M | $2.4M | 0.93% | -- | 2026-06-30 |
← Scroll →